‹ TWST latest research

TWST (Twist Bioscience Corporation): every AI call and what happened next

TradeFlare's AI research teams analysed TWST on 36 market nights between May 11, 2026 and October 9, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

36 calls 15 BUY · 19 HOLD · 2 SELL BUY calls up after 20 trading days: 12 of 15
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 9, 2026 HOLD $152.05 — / — not yet not yet
The current market regime and the stock's price state do not support a buy decision.
October 8, 2026 HOLD $155.65 — / — not yet not yet
The current market and stock-specific factors do not present a clear, high-conviction trading opportunity.
October 7, 2026 HOLD $166.97 $200.36 / $125.23 not yet not yet
The stock has already run significantly and exhibits high volatility, suggesting a period of consolidation or potential pullback is more likely than immediate further upside.
October 6, 2026 HOLD $205.00 — / — -9.4% not yet
The current setup does not warrant a BUY.
October 5, 2026 HOLD $188.67 — / — -25.9% not yet
The current market regime and stock-specific flags suggest caution and a lack of strong conviction for a new entry.
October 2, 2026 HOLD $188.05 — / — -15.3% not yet
The stock exhibits high volatility and a recent run-up, suggesting a period of consolidation or potential pullback is more likely than immediate sustained upside.
October 1, 2026 HOLD $193.24 — / — -19.1% not yet
The current market regime and the stock's price state suggest a period of consolidation or potential pullback.
September 30, 2026 HOLD $186.13 — / — -19.4% not yet
The current setup does not warrant a BUY.
September 29, 2026 HOLD $179.60 $206.54 / $152.66 -10.3% not yet
The stock is extended and showing signs of resistance, making a short-term HOLD appropriate to reassess.
September 8, 2026 HOLD $124.72 — / — +7.8% +30.4%
The current market regime and stock-specific factors do not support a BUY decision.
September 7, 2026 HOLD $124.72 — / — +7.8% +30.4%
The current market regime and stock-specific signals do not warrant a buy.
September 4, 2026 HOLD $128.71 — / — +8.0% +64.4%
The current market regime and the stock's internal signals do not warrant a buy at this time.
August 27, 2026 BUY $150.06 $225.09 / $127.55 -15.9% +19.4%
The post-earnings drift signal suggests momentum could persist for several weeks.
August 26, 2026 HOLD $151.42 — / — -12.7% +22.6%
Post-earnings drift signal from scanner.
August 25, 2026 HOLD $140.80 — / — -12.8% +4.7%
Continued positive sentiment from AI-related advancements and partnerships.
August 24, 2026 BUY $145.59 $175.59 / $123.65 -1.3% +16.9%
The post-earnings drift signal suggests a short-term trading opportunity.
August 22, 2026 BUY $145.59 $174.71 / $123.65 -1.3% +16.9%
The post-earnings drift signal suggests a short-term upward momentum.
August 13, 2026 BUY $125.21 — / — +8.8% +1.5%
Continued post-earnings drift if the initial positive momentum sustains.
July 28, 2026 BUY $86.54 — / — +12.3% +71.0%
Strong revenue growth and healthy gross margins indicate market demand.
July 7, 2026 BUY $99.24 — / — +1.6% +9.2%
The stock is currently in a strong uptrend technically, but fundamental and sentiment analysis are neutral, and the risk profile is high.
July 6, 2026 BUY $99.24 — / — -9.6% +1.1%
The stock is currently in a strong uptrend technically, but fundamental and sentiment analysis are neutral, and the risk profile is high.
July 3, 2026 BUY $99.24 $124.05 / $84.37 -9.6% +1.1%
The technical setup suggests an uptrend with potential for further upside, and the fundamental path to profitability, while long-term, provides a basis for holding through this period.
July 2, 2026 HOLD $102.25 — / — -8.7% -7.8%
Continued strong revenue growth and positive analyst sentiment.
July 1, 2026 BUY $102.88 — / — -8.4% -10.7%
Continued positive analyst sentiment and increasing institutional ownership.
June 30, 2026 BUY $98.36 — / — -13.1% -16.9%
Continued strong revenue growth and high gross margins.
June 18, 2026 BUY $82.87 $103.59 / $70.44 +14.0% -0.1%
The post-earnings drift signal suggests continued upward momentum over the coming weeks.
June 17, 2026 BUY $84.95 $106.19 / $72.21 +16.6% +13.2%
The post-earnings drift pattern suggests momentum could persist for several weeks.
June 1, 2026 BUY $66.87 $83.59 / $56.84 +3.2% +51.6%
The post-earnings drift pattern suggests momentum could persist for several weeks.
May 29, 2026 BUY
Published signal · reached target +25.0%
$69.03 $82.84 / $58.68 +3.5% +47.1%
The post-earnings drift pattern suggests a sustained upward move over the coming weeks.
May 19, 2026 SELL $49.17 — / — +29.6% +67.4%
The scanner identified a potential oversold bounce signal based on RSI.
May 18, 2026 SELL $49.17 — / — +30.3% +70.6%
The scanner identified a potential oversold bounce signal based on RSI.
May 15, 2026 HOLD $52.95 — / — +23.2% +64.3%
Continued positive analyst sentiment and potential for further product launches.
May 14, 2026 BUY $54.39 $65.27 / $46.23 +11.1% +43.9%
The current market regime is neutral, and while fundamentals and sentiment are bullish, technicals are neutral, and the risk score is high, necessitating a clearer catalyst for entry.
May 13, 2026 HOLD $55.95 — / — -1.3% +36.1%
Continued positive revenue growth and raised guidance from recent earnings.
May 12, 2026 HOLD $56.21 — / — -11.5% +21.1%
May 11, 2026 HOLD $56.85 — / — -11.4% +24.6%
Continued strong revenue growth in AI-enabled drug discovery.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.